¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"antigen shift"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
1
ÆäÀÌÁö:
8
¿µ¹®
ÇѱÛ
T-cell antigen receptor
T¼¼Æ÷Ç׿ø¼ö¿ëü
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
13
ÆäÀÌÁö:
8
¿µ¹®
ÇѱÛ
serologically defined antigen
Ç÷ûÇÐÀû±ÔÁ¤Ç׿ø
soluble antigen
¼ö¿ë¼ºÇ׿ø
somatic antigen
ü¼¼Æ÷Ç׿ø, ±ÕüÇ׿ø
specific antigen
ƯÀÌÇ׿ø
surface antigen
Ç¥¸éÇ׿ø
thymus-dependent antigen
°¡½¿»ùÀÇÁ¸Ç׿ø
thymus-independent antigen
°¡½¿»ùºñÀÇÁ¸Ç׿ø
transplantation antigen
À̽ÄÇ׿ø
tumor antigen
Á¾¾çÇ׿ø
type specific antigen
ÇüƯÀÌÇ׿ø
human leukocyte antigen complex
»ç¶÷¹éÇ÷±¸Ç׿øº¹ÇÕü
human leukocyte antigen complex gene
»ç¶÷¹éÇ÷±¸Ç׿øº¹ÇÕüÀ¯ÀüÀÚ
T cell antigen receptor
Ƽ¼¼Æ÷Ç׿ø¼ö¿ëü
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
8
¿µ¹®
ÇѱÛ
antigen antibody interaction
Ç׿øÇ×ü»óÈ£¹ÝÀÀ.
antigen binding capacity
Ç׿ø°áÇÕ´É(¡Ì¿ùêÒö).
antigen binding fragment
Ç׿ø°áÇÕºÎÀ§
antigen binding receptor
Ç׿ø°áÇÕ¼ö¿ëü
antigen binding site
Ç׿ø°áÇÕºÎÀ§
antigen capture assay
Ç׿øÆ÷È¹ÃøÁ¤
antigen combining site
Ç׿ø°áÇպΠ(¡Ì¿ùêÝ»).
antigen competition
Ç׿ø°æÀï.
antigen detection
Ç׿ø°ËÃâ
antigen diffusion constant
Ç׿øÈ®»ê»ó¼ö(ù÷ê«üªß¤ßÈâ¦).
antigen drift
Ç׿ø¼Òº¯ÀÌ.
antigen excess
Ç׿ø°ú´Ù(ù÷ê«Î¦Òý).
antigen excess zone
Ç׿ø°úÀ×´ë.
antigen excess zone
Ç׿ø°úÀ×´ë.
antigen excess zone
Ç׿ø°úÀ×´ë.
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
8
¿µ¹®
ÇѱÛ
antigen, histocompatibility
Á¶Á÷ÀûÇÕÇ׿ø
antigen, homologous
µ¿Á¾Ç׿ø
antigen, human leukocyte (HLA)
»ç¶÷ ¹éÇ÷±¸Ç׿ø, HLAÇ׿ø
antigen, inaccessible
°Ý¸®Ç׿ø
antigen, incomplete
ºÒ¿ÏÀüÇ׿ø
antigen, labelled
Ç¥ÁöÇ׿ø
antigen, leukocyte
¹éÇ÷±¸Ç׿ø
antigen, lymphocyte defined (LD)
¸²ÇÁ±¸ Ç¥¸éÇ׿ø, LDÇ׿ø
antigen, major histocompatibility
ÁÖÁ¶Á÷ÀûÇÕÇ׿ø, MHCÇ׿ø
antigen, particulate
ÀÔÀÚÇ׿ø
antigen, polymerized
ÁßÇÕüÇ׿ø
antigen, private
°³ÀÎÇ׿ø, °³º°Ç׿ø
antigen, protective
¹æ¾îÇ׿ø
antigen, public
ÀϹÝÇ׿ø, °øÅëÇ׿øcf.private antigen
antigen, self
ÀÚ°¡Ç׿ø, ÀÚ±âÇ׿ø
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
8
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
8
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
8
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
8
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
8
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
8
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½